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ASSESSING THE OUTCOME OF RELAXING RETINECTOMY IN TREATING 
RECURRENT RHEMAGTOGENOUS RETINAL DETACHMENTS 
GOPAL D. AMIN 
ABSTRACT 
 The purpose of this study is to evaluate the effectiveness of pars plans vitrectomy 
with relaxing retinectomy as treatment for recurrent rhegmatogenous retinal detachments 
(RRD) complicated by proliferative vitreoretinopathy (PVR).  
This retrospective case series was conducted with data from a single retina 
surgeon at Beth Israel Deaconess Medical Center. The medical records of 101 patients 
who underwent pars plana vitrectomy (PPV) with relaxing retinectomy for retinal 
detachment with PVR between January 2006 and August 2016 were identified. 
Exclusionary criteria eliminated patients with proliferative diabetic retinopathy, tractional 
retinal detachments, and open globe trauma, leaving a total of 57 participants (n=57 eyes) 
with rhegmatogenous retinal detachment complicated by PVR of grade C or more. All 
participants were initially treated with three-port PPV with membrane peeling combined 
with relaxing retinectomy, barrier endolaser photocoagulation, and silicone oil 
tamponade (n=48) or gas tamponade with SF6 (n=7) or C3F8 (n=2). The primary 
outcome measures were complete retinal reattachment for a minimum of 3 months and 
final visual acuity. 
Final anatomical success was achieved in all 57 patients. Successful reattachment 
was observed after one surgery in 40 of 57 eyes (70.2%). Sixteen of the 17 re-
detachments were successfully reattached after one reoperation. One case required a third 
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surgery to achieve complete reattachment. Four patients developed hypotony defined as 
intraocular pressure (IOP) < 5 mmHg (7%). A significant difference between pre- and 
postoperative best corrected visual acuity (BCVA) was defined as a change by at least 2 
snellen lines. Of the 50 patients for whom BCVA was documented, visual acuity 
improved in 27 patients (63%), remained the same in 10 patients (23%), and worsened 6 
patients (14%). Thirty-seven (87%) participants overall were had visual acuity greater or 
equal to 5/200 at 3-months post-operatively. 
Our study demonstrated good anatomic and visual outcomes after retinectomy for 
patients with RRD associated with PVR, which were significantly better than outcomes 
in the Silicone Oil Study Report 5. The high rate of success reported in our study is likely 
due to improved technology and techniques, and possibly the proactive use of 
retinectomy in less severe cases of PVR. The results of our study demonstrate that the use 
of relaxing retinectomy in patients with RRD and PVR provides an effective method for 
definitively relieving retinal traction and improving anatomic and visual outcomes. 
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INTRODUCTION 
 
The human eye serves as the major sensory bridge between the world and brain. 
Traditionally, the eye can be classified in two major anatomical parts: the posterior and 
anterior segments (Kolb, 1995). The anterior segment contains the anterior and posterior 
chamber. The anterior chamber includes the cornea, iris and lens while the posterior 
chamber includes the vitreous, retina, choroid, and optic nerve.  
 
 
Figure 1: Structure of the Eye. This diagram depicts the structure of the human eye. 
The cornea, lens, and iris fall in the anterior chamber of the anterior segment. The 
posterior chamber of the anterior segment includes the vitreous, retina, choroid, and optic 
nerve. Figure adapted from (Wright et al., 2010). 
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Retina 
The retina is a light sensitive multilayered structure of the eye that is found the 
posterior chamber of the anterior segment (Kolb, 1995). The retina is made up of many 
different layers, with each layer being composed of either photoreceptors, neurons, or 
support cells. It is found between the vitreous and choroid. The retina is responsible for 
relaying visual input into electrical signals that are relayed to the visual cortex. 
 
 
Figure 2: Layers of the Retina. Light travels through these layers entering from the 
vitreous humor (anterior) and continuing towards the choroid (posterior): the inner 
limiting membrane, nerve fiber layer, ganglion cell layer, inner plexiform layer, inner 
nuclear layer, outer plexiform layer, outer nuclear layer, external limiting membrane, 
photoreceptor layer of rods and cones, and retinal pigment epithelium. Figure taken from 
(Willoughby et al., 2010). 
 
The retinal pigment epithelium cells (RPE) are found posterior to the retina, 
followed by the choroid (Kolb, 1995). The RPE cells are responsible for nourishing the 
retina, recycling vitamin A in the visual cycle, and preventing fluid accumulation 
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between the retina and RPE (Wright et al., 2010). The choroid is a highly vascularized 
layer of tissue which supports the outer layers of the retina. 
The macula is the central zone of the retina that is accountable for central vision  
(Willoughby et al., 2010). The fovea is the central part of the macula and is known to 
have the highest proportion of photoreceptors. The status of the fovea is important in 
determining the prognosis of retinal detachment cases. 
 
 
Figure 3: Fundus photo. Figure 3: Fundus photo. Fundus photos display the optic 
disc, macula, fovea, and associated blood vessels. A fundus photo can be taken when the 
eye is dilated for diagnostic purposes. Figure taken from (Willoughby et al., 2010). 
 
 
Retinal Detachment 
 Retinal detachment (RD) occurs when the neurosensory retina separates from the 
underlying RPE and choroid (Mitry et al., 2010). This separation from its normal position 
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results due to fluid buildup between these two layers or due to vitreous traction on the 
retina. Regardless of the etiology, RD results in ischemia of the retina and rapid, 
progressive photoreceptor degeneration. This condition is time sensitive in that large-
scale vision loss can be avoided by addressing the detachment as soon as possible. If no 
treatment is provided, the retina can become fully detachment and lead to loss of vision. 
Pathogenesis 
Many different forms of RD exist, and how they differ depends on the source of 
the detachment. Tractional retinal detachment (TRD) occurs when the vitreous membrane 
(collagen membrane that separates the vitreous humor from the rest of the eye) pulls on 
the retina and is common in patients with poorly controlled diabetes (Cruz-Iñigo et al.,, 
2014). This traction results in the detachment of the retina from the RPE. There tends to 
be no holes or tears present in TRD. The next form of RD is exudative retinal detachment 
(ERD), which occurs due to fluid accumulation underneath the retina. Fluid build-up is 
commonly caused by inflammatory conditions. The most common form of retinal 
detachment is the rhegmatogenous retinal detachment (RRD). In contrast to TRD, RRD 
occurs due to breaks or tears in the retina that are a commonly the result of vitreoretinal 
traction (Mitry et al., 2010). The traction allows vitreous fluid to build up under the 
photoreceptor layer of the retina and increase separation between the RPE and 
photoreceptors.  
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Complications  
Proliferative Vitreoretinopathy (PVR) is a condition that develops as a 
complication of RRD and is the most common reason of failure or surgical intervention 
for RRD (Pastor, 1998), (Charteris et al., 2007). PVR is defined as the growth and 
contraction of cellular membranes within the vitreous cavity and both retinal surfaces that 
result in exerting traction. The traction in combination with a retinal hole or tear allows 
for a build-up of sub-retinal fluid that ultimately leads to a RRD. The incidence of PVR 
in patients who have undergone surgery to treat primary RRD is 8-10% (Nagasaki et al., 
1998) (Pastor et al., 2002). 
 
Figure 4: Retinal Detachment via Proliferative Vitreoretinopathy. This illustration 
demonstrates the tractional forces present due to PVR on the retina the results in retinal 
detachment. Figure taken from (Quiram et al., 2006). 
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PVR is graded as Grade A, B, or C: Grade A is characterized by the appearance of 
vitreous haze and RPE pigment clumps in the vitreous, Grade B by the wrinkling of the 
inner retinal surface, and Grade C by the presence of retinal folds(Hilton et al., 1983). 
 
Table 1: The Classification of Proliferative Vitreoretinopathy. Different grades of 
proliferative vitreoretinopathy are characterized by different clinical signs. Table 
modified from (Machemer et al., 1991). 
Grade Clinical Signs 
A Vitreous Haze, vitreous pigment clumps 
B Wrinkling of inner retinal surface, rolled 
edge retinal break 
C Full thickness fixed retinal folds 
C-1 One quadrant with fixed retinal folds 
C-2 Two quadrants with fixed retinal folds 
C-3 Three quadrants with fixed retinal folds 
 
Diagnosis 
RRD is commonly preceded by a posterior vitreous detachment (PVD) which is a 
condition in when the vitreous membrane separates from the retina. PVD is correlated 
with photopsia (flashes of light) and a sudden increase in the number of floaters which 
are detached vitreous bits that float in the vitreous humor that cause a perceived shadow 
in vision (Johnson, 2010).  
Risk factors for RD include severe myopia, previous complications from cataract 
surgery, family history of RDs, or a previous RD in the other eye (Feltgen & Walter, 
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2014). Myopic patients are at greater risk for RRD due to lattice degeneration (LD), 
which is the thinning of the peripheral retina. This thinning results in the peripheral retina 
forming crisscross pattern of a lattice with small holes, hence the name lattice 
degeneration. Myopic eyes have a higher incidence of LD because they are known to be 
larger than normal eyes and are more prone to stretch out the peripheral retina. In contrast 
to this physical stretching, cataract surgery increases the liquefaction of the vitreous and 
by doing so increases the risk of PVD thereby increasing the risk for a RRD (Mitry et al., 
2010).  
The cases of PVD that lead to RDs tend to have the subsequent symptoms: a 
shadow that covers some part of central vision (commonly referred to as a curtain or 
veil), straight lines that suddenly appear curved, and central visual loss (Feltgen & 
Walter, 2014). 
Fundus Examination 
The primary method to diagnose RRD is by performing a dilated fundus exam. 
During the exam, the presence of a Schaeffer’s sign will indicate RPE cells (pigment) in 
the vitreous. When visualizing, the fundus using indirect ophthalmoscopy, the posterior 
eye must be checked for separation of the retina. The presence of a hole or tear will most 
likely be located peripherally.  
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Figure 5: Fundus Photo of a Retinal Detachment. A superotemporal rhegmatogenous 
retinal detachment. Figure taken from (Strobhen & Sohn, 2013). 
 
Optical Coherence Tomography 
Optical coherence tomography (OCT) is an imaging test that implements light 
waves to generate cross-sectional photos of the retina (Hee et al., 1995), (Huang et al., 
1991). Producing metrics such as macular thickness, these images can help with the 
detection and treatment of serious retinal conditions. An OCT is not the diagnostic tool of 
choice for identifying a RRD, however, it can be useful for determining the status of the 
macula as well as TRD and ERD. 
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Figure 6: Optical Coherence Tomography of a Retinal Detachment. The retina is 
detached from the RPE temporally (right). Figure taken from (Strobhen & Sohn, 2013). 
 
B-Scan 
Ultrasonography uses sound waves to capture images of the internal eye. This 
procedure is helpful in detecting RD and tumors in the posterior chamber when 
ophthalmoscopy is insufficient (Kendall et al., 2015). In the case where the vitreous 
media is not clear, either due to vitreous hemorrhage (bleeding in the eye) or severe 
cataract, a fundus exam may prove to be futile in diagnosing a RD. Instead, B-scan 
imaging should be conducted to identify RD.  
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Figure 7: B-Scan of a Normal Eye and a Retinal Detachment. The image on the left 
depicts a B-scan of an individual without a retinal detachment, while the image on the 
right shows the neurosensory retina (white layer) detached from the RPE. Figure taken 
from (Aironi & Gandage, 2009) 
 
Treatment 
Treatment for RD depends upon its type and size. TRD as well as exudative RD 
are managed by treating the disease that resulted in RD. However, if traction threatens the 
macula, a vitrectomy is required. More severe cases of TRD can cause a tear or hole, 
resulting in a RRD. A small RRD requires cryotherapy or laser photocoagulation of the 
break to prevent the break from growing in size. For a larger RRD, more intense 
treatment options are required: the pneumatic retinopexy (non-surgical), scleral buckle, or 
pars plana vitrectomy. 
An emergency case is typically determined by whether the macula is still 
attached. If the macula is still attached, the RD should be treated within 24 hours. This is 
known as a “mac-on” RD and is urgent because the prognosis for recovery of central 
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vision is much greater than if the macula had detached (mac-off RD). However, a mac-
off RD should be operated on within one week.  
Pneumatic Retinopexy 
Historically the first notion of pneumatic retinopexy (PR) can be dated back to the 
early 1900s, however the modern PR was introduced in 1986 by Dr. George Hilton and 
Dr. W. Sanderson Gizzard (Hilton & Grizzard, 1986). The benefits of this procedure are 
that it is minimally invasive, cost effective, and can be done in an outpatient clinic. The 
procedure entails freezing areas of the retina around the retinal break and injecting an 
expandable gas bubble into the vitreous cavity in an attempt to reattach the retina to the 
RPE. Theoretically, the surface tension seals the hole to prevent further sub-retinal fluid 
from accumulating and allows the RPE to pump the sub-retinal fluid out and reattach to 
the retina. Due to the use of the gas bubble, some patient positioning is required after the 
procedure that can span from one to five days.  
PR leads to reattachment 70-80% of the time and can be the first option in treating 
first time RRD patients due to the minimal invasion required. A study done by Han in 
1998 compared the effectiveness of PR versus scleral buckle in the treatment of RRD. 
The primary reattachment rate of PR ranges from 51-62% (Han et al., 1998) (Ross et al., 
2008). This rate is lower than the overall reattachment rate achieved by using PR. Re-
detachment, if any, tends to take place soon after PR. These patients will either undergo a 
scleral buckle or pars plana vitrectomy, both of which are more effective but also more 
invasive procedures. 
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Scleral Buckle 
The scleral buckle (SB) and can be drawn to the works of C.L. Schepens, Ernst 
Custodis, and Hermengildo Arruga. In principle, the SB aims to reestablish proximity 
between the detached retina and RPE (Schepens et al., 1957). This is done by the use of 
silicone bands that are placed on the sclera and sutured to form an indentation. This 
indentation is what collapses the space between the detached retina and the RPE. The 
mechanism of how SB repairs the detachment is not fully understood. However, the SB is 
believed to work by narrowing the distance between the RPE and the retina as well as 
reducing traction. There are many types of scleral buckles depending on the location of 
the retinal breaks: radial, circumferential, and encircling buckles. The SB is known to 
have a much higher primary reattachment rate than PR, proven by multiple studies with 
consistent rates somewhere in the range of 80-90% (Han et al., 1998). 
Pars Plana Vitrectomy 
The pars plana vitrectomy (PPV) was created by Dr. Robert Machemer who is 
considered to be the father of modern retina surgery. The PPV requires 3 key 
instruments: the use of a light pipe, an infusion port, and a vitreous cutting device 
(Machemer et al., 1971) (Machemer, 1995). The PPV is able to enhance the visualization 
of retinal breaks and tears which also improves the ability to remove retinal traction. To 
remove the vitreous, the vitreous cutter is introduced into the vitreous through the pars 
plana, and cuts the vitreous in order remove it. To maintain pressure in the eye, a salt 
solution is introduced via the infusion port as the vitreous is removed. All of this is done 
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with the function of the light pipe that illuminates the inside of the eye. In RRD 
treatment, the final step involves inserting an intraocular tamponade to seal the break. 
Silicone oil is more commonly used in cases associated with PVR. An advantage of the 
PPV is that method of entry of the three surgical instruments through the pars plana 
avoids potential damage to the retina and crystalline lens. One disadvantage is that a 
vitrectomy is known to hasten the occurrence of cataract. The PPV is the most common 
method of treatment for RD.  
 
Figure 8: Pars Plana Vitrectomy. Figure 8a illustrates the external eye with 
three access ports. Figure 8b depicts the intraocular view during a vitrectomy. Image was 
taken from (Feltgen & Walter, 2014). 
 
Intraocular Tamponade 
The PPV to treat a RD is involves the use of an intraocular tamponade (Silcone 
Study Report 1, 1992). An intraocular tamponade is refers to a liquid or gas medium 
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being inserted into the eye. In 1962, Cibis reported the use of silicone oil for treatment of 
RD (Cibis et al., 1962). Tamponade was used in 1970 by Cockerham:  
 
“Silicone injection has two purposes: to free adhesions between vitreous 
membranes and the retina and to forcibly tamponade the retina against the 
choroid” (Cockerham et al., 1970). 
 
In the context of RD surgery, tamponade agents are used to provide surface 
tension across retinal breaks that have been sealed by photocoagulation or cryotherapy. 
The tamponade is used to prevent fluid from flowing through a sealed retinal break 
underneath the retina, rather than adjusting the retina back into place(Vaziri et al., 2016). 
Tamponade agents used today include various gases and silicone oil. The 
difference lies in the duration each agent provides. Gas tamponades are temporary in 
nature and are spontaneously resorbed from the vitreous cavity over time (Cockerham et 
al., 1970). Each gas used due to its intrinsic properties will have different durations. A 
silicone oil tamponade is permanent and can only be removed after another PPV. The 
permanence of the silicone oil removes the worry of duration however with an additional 
surgery comes additional risks. When deciding which tamponade to use, it is important to 
evaluate the duration of time the tamponade will be required in the vitreous cavity. 
Silicone oil tamponade does have its fair share of risk; one complication in particular is 
emulsification. In this case, emulsification prevents the miniature silicone oil bubbles 
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from rejoining. This could lead to complications such as keratopathy and glaucoma 
(Miller et al., 2014). 
 
Table 2: Characteristics of Intraocular Tamponades. This table compares 4 gas 
tamponades along with silicone oil. As seen below, the gas tamponades due to its 
physical and chemical properties, tend to exert a greater surface tension than the silicone 
oil. However, the duration of the silicone is the longest with it being permanent. Table 
was adapted from (Vaziri et al., 2016). 
 
 Chemical 
Formula 
100% Gas 
Expansivity 
100% Gas 
Maximum 
Expansion 
Tamponade 
Duration 
Interfacial 
Tension 
(mN/m) 
Air N/A N/A N/A 5-7 days 70 
Sulfur 
hexafluoride 
SF6 2x 1-2 days 2 weeks 70 
Perfluoroethane C2F6 3x 1-3 days 4-5 weeks 70 
Perfluoropropane C3F8 4x 3-4 days 8 weeks 70 
Silicone Oil PDMS N/A N/A permanent 35 
PDMS = Polydimethylsiloxane 
 
Relaxing Retinotomy  
 Introduced by Machemer in 1981, the relaxing retinotomy was invented to deal 
with RRD complicated by PVR (Machemer, 1981). A retinotomy refers to the cutting of 
the retina (Blumenkranz et al., 1993). In the circumstance of a RRD complicated by PVR, 
a retinotomy is done where there is retinal shortening or fibrosis in locations that lead to 
the formation of retinal breaks. A relaxing retinotomy can also be performed to flatten a 
retina that cannot be flattened by an internal tamponade. Relaxing retinotomies are 
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performed with the vitreous cutters, and focus is given to the anterior retinal flaps before 
they are cut. Once all the traction is relieved and laser photocoagulation treatment is used 
to seal the edges of the retinotomy, a tamponade is used to prevent fluid from entering the 
sub-retinal space in case of breaks.  
The key difference between a retinotomy and retinectomy is that a retinotomy 
refers to cutting the retina, while a retinectomy refers to removing nonessential retinal 
tissue. In another sense, all retinectomies can be considered as retinotomies due to the 
fact that both techniques require the cutting of the retina. For this reason, in this study 
patients who have undergone retinotomies as well as retinectomies will be included. For 
the sake of simplicity both of these procedures will be addressed as retinectomy going 
forward. 
 The relaxing retinectomy has been evaluated in multiple studies to determine its 
efficacy as treatment against RRD complicated by PVR. These studies show a similar 
trend: the relaxing retinectomy is effective in reattaching the retina, however, visual 
recovery’s improvement rate is not as large as the reattachment rate (Kolomeyer et al., 
2011), (Grigoropoulos et al., 2007), (Tseng et al., 2005), (Metge et al., 1997), 
(Blumenkranz et al., 1993), (Morse et al., 1990). 
 
Visual Acuity 
 Central Visual Acuity (VA) refers one’s ability to see clearly. VA depends on 
many factors including the clarity of the ocular media, whether the image is being 
focused on the retina, and lastly whether the afferent visual pathway as well as visual 
	17 
cortex are functioning. Conducting VA exams are an efficient method to test the overall 
functionality of the eye. Visual acuity is measured by using a Snellen chart, created by 
Dutch ophthalmologist Herman Snellen in 1862. The normal Snellen chart is printed with 
eleven lines of block letters. These “letters” are formally known as optotypes. The first 
line consists of one very large optotype and as the lines progress the number of optotypes 
increase while the size of each optotype decreases. A reference value which VA is 
considered standard is called 20/20 vision or 6/6 vision in the metric system. At 20 feet or 
6 meters, a human eye with that performance is able distinguish optotypes. 
 
Silicone Study Report 5 
 The Silicone Oil Study was a multi-centered, randomized clinical trial designed to 
evaluate the use of intraocular tamponades after vitrectomy in eyes with PVR 
(Blumenkranz et al., 1993). The Silicone Study Report 5 is a study submitted for 
publication in 1993, which aimed to obtain the anatomical and visual outcomes of a 
relaxing retinectomy in patients who have and have not been previously vitrectomized. 
The results of this study are considered to be a standard of comparison in the field of 
vitreous surgery.  
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Specific Aims and Objectives 
The primary goal of this study is to investigate the outcome of PPV with relaxing 
retinectomy in patients with RRD complicated by PVR. This study aims to analyze the 
prognosis of patients that underwent PPV with relaxing retinectomy and compare them to 
those patients from The Silicone Study Report 5 in terms of visual outcomes and whether 
the retina was successfully re-attached. With it being over 30 years since the publication 
of The Silicone Study Report 5, the current study aims to update findings on these 
outcomes. 
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METHODS  
 
Inclusion Criteria 
This retrospective case series was conducted with data from a single retina 
surgeon at Beth Israel Deaconess Medical Center. The medical records of 101 patients 
who underwent PPV with relaxing retinectomy (or retinotomy) for RRD with PVR 
between January 2006 and August 2016 were identified. Exclusionary criteria eliminated 
patients with proliferative diabetic retinopathy, traction retinal detachments, and open 
globe trauma, leaving a total of 57 participants (n=57 eyes) with RRD complicated by 
PVR of grade C or more. All participants were initially treated with three-port PPV 
combined with relaxing retinectomy, barrier endorser photocoagulation, and silicone oil 
tamponade (n=48) or gas tamponade with SF6 (n-7) or C3F8 (n=2). The primary 
outcome measures were complete retinal reattachment for a minimum of 3 months and 
final visual acuity.  
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Figure 9: Study inclusion flow chart. This chart illustrates that only cases with PVR 
grade C or above that underwent combined PPV-retinectomy were included in the study, 
excluding cases of PDR, Tractional RD, and open globe trauma. 
 
 
Logarithm of the Minimum Angle of Resolution (LogMAR)  
In order to compare the various postoperative and preoperative visual acuities, the 
logMAR scores were used (Holladay, 1997). The visual acuities were converted from 
Foot scale into the LogMAR score via the following equation:  
 
LogMAR= - Log (20/Distance of the best line read in feet)  
 
	21 
The conversion chart below was used.  
 
Table 3: Conversion between vision in feet scale to LogMAR score. Table was 
adapted from (Holladay, 1997). 
Visual Acuity (Feet) LogMAR 
Hand Motion (HM) 5/2000 2.6000 
Count Fingers (CF) 5/200 1.6000 
20/400 1.3010 
20/200 1.0000 
20/150 0.8751 
20/100 0.6990 
20/80 0.6021 
20/70 0.5441 
20/60 0.4771 
20/50 0.3979 
20/40 0.3010 
20/30 0.1761 
20/25 0.0969 
20/20 0.0000 
 
 
Diagnosis 
Before undertaking any surgical interventions, a complete dilated 
ophthalmoscopic examination was performed to ensure the appropriate diagnosis. If at 
that time the opthalmoscopic exam was not sufficient to obtain an accurate diagnosis 
either due to dense cataracts or vitreous hemorrhage, a B-scan ultrasound was conducted. 
Once the diagnosis was confirmed to ensure the patients were fully informed, the patient 
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was provided information on retinal detachments including its origin, progression, 
treatment options, its potential recurrence, and prognosis. While discussing treatment 
options, PPV with relaxing retinectomy, the physician determined the urgency of the 
detachment (whether it was macula on or off) to see if the surgery needed to be 
completed within the next 1-2 days (macula on) or could it be scheduled within the next 
7-10 days (macula off).  
If the patients chose to follow through with a surgical treatment, they were 
informed that any intraocular procedures are associated with a 1 in 1,000 risk of bleeding 
and infection which can lead to total loss of vision. Any patient who undergone retina 
surgery was at risk of developing retinal tears or retinal detachment in approximately 1 in 
100 patients. This problem could typically be corrected at the time of surgery or may 
require additional surgery. It was also noted that the vitrectomy is associated with 
postoperative cataract formation in most patients over the age of 50 years of age. Once 
the patient was fully informed on their diagnosis, the treatment options, and potential 
risks, they signed consent forms and were scheduled for the next available surgery date.  
 
Surgical Procedure 
At the operating room, EKG, O2, and blood pressure monitors were placed and 
monitored throughout the case. The operative eye was prepped and draped in the usual 
ophthalmic fashion and a wire lid speculum was placed to keep the lid apart. A 
retrobulbar infusion of a 50:50 mixture of 2% lidocaine and 0.75% Marcaine with 
epinephrine was given behind the operative eye to produce suitable anesthesia and 
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akinesia. Sclerotomies were made 3.5 mm posterior to the limbus in the superonasal, 
superotemporal, and inferotemporal quadrants. A 4-mm infusion cannula was inserted 
into the inferotemporal sclerotomy. The tip of the infusion cannula was inspected to 
ensure that it was in the vitreous cavity prior to turning on infusion (PPV with relaxing 
retinectomy surgical protocol at Beth Israel Deaconess Medical Center). 
The light pipe and vitreous cutter were then used to perform a revision vitrectomy 
(central, peripheral or both depending on each individual case). At this point, if the 
patients had previous silicone oil tamponade, all of it was removed from the back of the 
eye. If the patient also had an epi-retinal membrane diagnosis, it would be addressed at 
this point: Kenalog (triamcinolone acetonide) was injected to stain the ERM. ILM 
forceps were used to peel the ERM. Once this was achieved, then if ILM peeling was 
intended, then ICG dye was used to stain at varying durations depending on the surgeon’s 
preference. If the staining was not sufficient, re-staining was attempted. Once sufficient 
staining was achieved, the ILM was peeled (PPV with relaxing retinectomy surgical 
protocol at Beth Israel Deaconess Medical Center). 
Attention was then paid to the site of retinal detachment. Perfluorocarbon oil was 
instilled via fluid air exchange to maintain attachment for parts of the retina that were 
attached prior to surgery (if any). Areas of detachment were then identified and the 
vitreous cutter was used to create a relaxing retinotomy (excising the retina) so that the 
retina would flatten out nicely. Further perfluorocarbon oil was instilled to flatten out the 
retina. The endolaser probe was then used to apply barrier endolaser photocoagulation 
treatment around the edges of the retinotomy. Once completed, a 360-degree scleral 
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depressed examination was performed, and the surgeon would search for any evidence of 
retinal tears or detachments. Subsequently, if none were found, the perfluorocarbon oil 
was removed from the eye carefully after which, a determined amount of silicone oil was 
infused into the vitreous cavity until it was completely full (PPV with relaxing 
retinectomy surgical protocol at Beth Israel Deaconess Medical Center). 
The sclerotomies were then closed and ensured to be water-tight. The pressure in 
the eyes were checked at the conclusion of the case. A subconjuctival injection of Kefzol 
and dexamethasone were given. The Operative eye was patched with 1 drop of 
scopolamine 0.25%, bacitracin ointment, a soft eye pad and a hard eye shield. The patient 
was the taken to the recovery room (PPV with relaxing retinectomy surgical protocol at 
Beth Israel Deaconess Medical Center). 
 
Statistical analysis  
Statistical analyses were performed through a paired T-test to compare 
preoperative and postoperative BCVA. Data are presented as means ± SEM. Analysis 
was also conducted via chi-squared test to compare the primary reattachment rates as 
well as the final visual outcomes of the current investigation versus The Silicone Study 
Report 5. Statistical analysis was run on SAS software edition (9.4). Statistical analyses 
were accepted as significant with a p value of <0.05.  
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RESULTS 
Baseline Characteristics 
 Fifty-seven consecutive eyes with PVR grade C or above with RRD were 
included in this study. Thirty-four patients were males and 23 were females with a 
median age of 64 years (range, 21-92 years). Table 1 summarizes the preoperative 
characteristics of the eyes that underwent PPV with relaxing retinectomy. Mean 
preoperative BCVA was 1.47 ± 0.0929 LogMAR. Eleven eyes (19.3%) had a macula-on 
RRD while the other 46 eyes (80.7%) were macula-off RRD. Fifty-seven eyes had at 
least one previous PPV in the eye in which the RRD occurred.  
 
Table 4: Preoperative Characteristics. 
(N=57) 
Age, median, years (range) 64 (21-92) 
Sex  
             Male 34 (59.6%) 
 Female 23 (40.4%) 
Etiology  
 RRD 57 (100%) 
Macula status at time of retinectomy   
Number (%)  
 Macula on 11 (19.3%) 
 Macula off 46 (80.7%) 
Preoperative BCVA, LogMAR 
(N=43 due to loss to follow up) 
1.47 
Previous vitrectomy 57 (100%) 
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Final Outcomes 
 Table 4 summarizes the outcomes of the PPV with relaxing retinectomy. 
Successful re-attachment of the retina was achieved in 40/57 (70.2%) eyes. Final 
outcomes resulted in a 100% retinal attachment. Macula-off retinal re-detachment 
occurred in 17 (29.8%) eyes due to re-occurrence of PVR. These eyes underwent an 
additional PPV with relaxing retinectomy. Mean preoperative BCVA improved 
significantly (P<0.001) from 1.69±0.13 to 1.28±0.11 LogMAR at the last postoperative 
visit (Figure 10). Also, postoperative hypotony was observed in 4 (7.1%) eyes. 
 
Table 5: Postoperative Results. 
Final follow-up (N=57) 
Primary complete retinal attachment 40/57 (70.2%) 
Final complete retinal attachment 57/57 (100%) 
Final macular attachment 57/57 (100%) 
Final visual acuity, median (LogMAR) 
(N=43 due to loss to follow up) 
1.28±0.11 
Retinal Macular re-detachment 17/57 (29/8%) 
Retinectomy number  
1 40 
>1 17 
Postoperative Intraocular Pressure  
0-10 mmHg 4 (7.1%) 
>10 mmHg 53 (93.9%) 
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Anatomical Outcomes 
 The first analysis conducted was by compiling data to see whether PPV with a 
relaxing retinectomy was able to successfully reattach the retina. It was determined after 
the study that the retina was successfully attached in all patients. Sixteen out of the 57 
patients required two surgeries to achieve re-attachment, and one out of the 17 required 
three surgeries. The control rate for one surgery in the Silicone Study Report 5 was 62%. 
Patients who had multiple surgeries tended to have a recurrent detachment within an 
average duration of 14.5 weeks.  
 
Table 6: Re-attachment rate of PPV with Relaxing Retinectomy. 57 eyes underwent 1 
surgery to reattach the retina, which resulted in a retinal reattachment rate of 70.2% 
compared to the control rate of 62% from the Silicone Oil Study Report 5. The statistical 
analysis determined that there is significant evidence that the reattachment rates differ 
between the current investigation (observed) and Silicone Study Report 5 (expected) 
(P<0.0001).  
 
 Reattachment rate Silicone Study Report 5 
Group 2 
reattachment rate 
1st Surgery 
(n=57) 
40/57 (70.2%) 44/71 (62%) 
2nd Surgery 
(n=17) 
16/17 (94.1%)  
3rd Surgery 
(n=1) 
1/1 (100%)  
 
Visual Outcomes 
Another analysis conducted was done by compiling data to see whether PPV with 
a relaxing retinectomy was able to significantly improve vision postoperatively. It was 
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discovered that when comparing the preoperative and postoperative visual acuity, the 
visual acuity (expressed as a LogMAR score) had significantly improved (P<0.0001) by 
decreasing a mean of 0.4163 ± 0.0929. (Figure). 
 
 
Figure 10: Visual outcomes of PPV/retinectomy. Preoperative and Postoperative visual 
acuities, converted into LogMAR score, of all treatment for RRD. Data presented as 
mean ± SEM; n=43 for the total number of eyes that underwent RRD surgery with no 
loss to follow up. The statistical analysis determined that there is significant evidence that 
the LogMAR scores decreased from preoperative to postoperative BCVA (p<0.0001). On 
average, the postoperative BCVA in LogMAR score was 0.42 (95% CI: 0.5, 0.77) lower 
than the preoperative BCVA. 
 
 
Consequently, using a control group from the Silicone Oil Study Report 5, a 
comparison was made to see how many patients had improved vision to count fingers at 5 
feet (5/200) or better by PPV with relaxing retinectomy. It was observed (via a Chi-
Squared test) that there was a significant difference (P<0.0001) in the percentage of 
	29 
patients with postoperative VA of 5/200 or better was 86% (n=37/43) of the patients, 
compared to 41% (n=27/71) of the Group 2 participants in the Silicone Study Report 5.  
 
Table 7: VA success of PPV with Relaxing Retinectomy in patients with previous 
PPV. Data presented as percentage of cohort with postoperative VA of count fingers or 
better. The statistical analysis determined that there is significant evidence that the final 
visual outcomes differ between the current investigation (observed) and Silicone Study 
Report 5 (expected) (P<0.0001).  
 
 Outcomes of PPV with 
Relaxing Retinectomy 
Silicone Study Report 5 
Group 2 cohort 
Percentage with 
Postoperative VA of 5/200 or 
better 
86% 
(n=37/43) 
41% 
(n=27/71) 
 
Best corrected visual acuity (BCVA) defined by improving by at least 2 Snellen 
lines was checked for in the 43 eyes for which BCVA was documented in and there was 
no loss to follow-up. BCVA improved in 27 eyes (62.8%), remained the same in 10 
(23.2%) eyes, and became worse in six eyes (14%). 
 
Table 8: Improvement in VA for patients without loss to follow-up.  
 
 Improved No change Worsened 
Number of eyes 27/43 (62.8%) 10/43 (23.2%) 6/43 (14%) 
 
 
In another analysis, an internal comparison was made to compare the preoperative 
and postoperative VA in patients who had primary re-attachment versus those patients 
who required multiple surgeries.   
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Figure 11: VA outcomes by number of PPV/retinectomy procedures. Preoperative 
and Postoperative visual acuities, converted into LogMAR score, of patients who 
required one PPV with relaxing retinectomy (blue) versus multiple procedures (red) for 
the treatment of RRD. Data presented as mean ± SEM; n=26 for the number of eyes that 
underwent one RRD surgery and n=17 for the number of eyes that underwent multiple 
RRD surgeries due to re-detachment.  
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DISCUSSION 
 
Interpretation of Results 
To date, relaxing retinectomy is regarded to be a technique that can help lead to 
retinal reattachment during PPV. The Silicone Study Report 5 reported that relaxing 
retinectomy may be required more often in patients undergoing repeated vitreous surgery 
(Blumenkranz et al., 1993). In this study, we have first demonstrated the overall efficacy 
of PPV with relaxing retinectomy in treating RRD complicated by PVR. The difference 
between the primary reattachment rate of patients who undergone PPV with relaxing 
retinectomy from the current study (70.2%) was significant (p<0.0001) compared to the 
reattachment rate of the Silicone Study Report 5 group 2 patients (62%) (Blumenkranz et 
al., 1993).  
The Silicone Study Report 5, characterized BCVA success as the patient 
possessing a LogMAR score of 1.6 (able to count fingers at 5 feet) at the 6 month follow 
up (Blumenkranz et al., 1993). Our current study showed a statistically significant higher 
percentage of patients at the count fingers mark when compared to the Silicone Study 
Report 5. In addition, an internal comparison was made between the preoperative and 
postoperative BCVAs depicted as LogMAR scores of patients who undergone PPV with 
relaxing retinectomy. There is significant evidence that the LogMAR scores decreased 
from preoperative to postoperative BCVA (p<0.0001). On average, the 
postoperative BCVA in LogMAR score was 0.42 (95% CI: 0.5, 0.77) lower than the 
preoperative BCVA. 
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Potential Confounders 
There are a few confounders to consider when determining what exactly is 
responsible for the change in reattachment rates as well as improved BCVA. Though the 
relaxing retinectomy technique has not changed much since its inception in the 1970s, 
there has been significant technological improvement in the vitreous surgical equipment 
used since the publishing of the Silicone Study Report 5 in 1993. Improvements can be 
linked to advancements in the size and design of equipment as well as the improvement 
in visualization during PPV. The development of small gauge PPV has many advantages: 
decreased surgical times, less vitreoretinal traction, rapid visual recovery, reduced 
inflammation and postoperative pain (Thompson, 2011). Improvement in equipment 
design of vitreous cutters as well as the enhancements of illumination through use of 
chandeliers could also have led to better prognosis (de Oliveira et al., 2016). This alone 
may be sufficient to explain the overall improved prognosis between the current 
investigation and the study conducted in Silicone Study Report 5. 
Recently, surgical practice leans towards an earlier surgical intervention. In the 
case of PVR, most of the patients who underwent PPV with relaxing retinectomy did so 
with a lower grade of PVR. Patients on average entered surgery with better visual 
prognosis, and exited with better visual prognosis. Due to the advancement in surgical 
equipment, surgeons are more comfortable with treating patients earlier in the 
pathogenesis of PVR knowing the earlier treatment prognosis outweighs the risks 
involved with every vitreoretinal surgery. 
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Limitations 
A limitation of this current investigation is the number of subjects used. The use 
of more patients with RRD complicated by PVR, would have helped us establish a 
stronger statistical relationship for anatomical and visual outcomes. In addition, the data 
presented, are treatments done by one surgeon which may be a potential confounding 
variable. Consequently, proposing a study that involves the collaboration of various 
physicians to compile a much larger database will address the number of subjects as well 
as eliminate the potential confounding variable.  
Another limitation was the follow up period. Many patients had loss to follow up 
after the 3-month mark, for this reason the 6 month and 24 month outcomes were not 
presented. If they were presented the number of participants in the study would have 
dropped even further decreasing the significance of our study. To further strengthen the 
results, we propose that future studies should obtain reattachment and VA notes at 6 
months as well as 24 months, since the majority of studies that publish outcomes of 
vitreous surgery tend to measure at 6 and 24 months. 
 
Closing Remarks 
This study was able to update the efficacy of achieving reattachment via PPV 
with relaxing retinectomy to treat RRD complicated by PVR compared to the Silicone 
Study Report 5. We then further demonstrated the improvement in postoperative BCVA. 
It can be concluded that performing relaxing retinectomies in cases of RRD with PVR 
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with unrelieved vitreoretinal traction is associated with better reattachment rates and 
improved vision in highly complex cases, and that it is appropriate in severe cases that 
require an aggressive traction-relieving. Due to the higher risks associated with relaxing 
retinectomy, it is not considered as a first option procedure for primary uncomplicated 
RRD. 
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